FDA and Compounding

In 2012 there was an outbreak of meningitis that caused 51 deaths and resulted in the illness of over 700 people that was related to the possible contamination of product coming from a compounding pharmacy, raising questions as to the nature of compounding and the regulation of that sector.  Because of the on-going nature of the scrutiny of this topic, this tab is being created as a repository to house various milestone related documents and videos associated with the public discourse around FDA’s regulation of compounding pharmacies.

Other Resources:

Share this:
Share this page via Email Share this page via Stumble Upon Share this page via Digg this Share this page via Facebook Share this page via Twitter

3 Responses to FDA and Compounding

  1. Pingback: Weekly Roundup – 4-19-13 | Eye on FDA

  2. Pingback: Weekly Roundup – 4-26-13 | Eye on FDA

  3. martin says:


    I was browsing your site, and noticed that you list the medical dictionary that the National Institutes of Health put together, on: [http://www.eyeonfda.com/resources-links]

    Honestly, thank you for mentioning them. I really can’t say enough positive things about what they do.

    It may be worthwhile to also mention AddictionLibrary.org, either above or below them. In my experience, the National Institutes of Health dictionary is amazing, but not very specific when it comes to addiction related terms.

    AddictionLibrary.org is part of a non-profit network, so you don’t have to worry about listing a commercial site.

    Thank you again, and keep up the great work.

    Take care.